Compare Supplements

Investigational — NO approved monotherapy dose. Phase-2 trials used once-weekly subcutaneous injection with stepwise escalation up to 4.5 mg maintenance. There is no approved standalone regimen; do not self-dose an unapproved drug.

Any time

Once-weekly subcutaneous injection (investigational only)

30mg elemental iron

Between meals

Ferrous bisglycinate (gentle, well-absorbed) or iron protein succinylate

• Not a dietary supplement and not an approved standalone drug — investigational; do not self-source grey-market vials
• History of pancreatitis (amylin/incretin-class caution)
• Pregnancy and breastfeeding

• Oral medications (delayed gastric emptying)
• Insulin / insulin secretagogues (sulfonylureas)
• GLP-1 / incretin drugs (e.g. semaglutide)

• Hemochromatosis or iron overload
• Repeated blood transfusions
• Adequate iron stores (test first!)

• Thyroid medications (levothyroxine)
• Antacids, PPIs
• Antibiotics (fluoroquinolones, tetracyclines)